Pediatric rheumatology

A simple questionnaire to prevent blindness: a cross-sectional study screening for Stickler syndrome in children

Rheumatology (Oxford)Published Cross-sectional study

Authors' conclusion

We demonstrate a clinically powerful screening tool capable of identifying children with underlying STL1, and thus this questionnaire can now be applied to at-risk children to inform the need for further specialist assessment.

Study context

Population
Children aged 4–10 years with and without COL2A1-confirmed STL1, recruited from a single specialist centre and online via Stickler Syndrome UK
Participants
28 vs 26
Exposure
COL2A1-confirmed STL1 vs general paediatric population
  • STL1n = 28
  • General paediatricn = 26reference
Outcome
Median final score of the screening tool (questionnaire)
Methodological detailsscreening tool (questionnaire) evaluation, single specialist centre and online recruitment
  • Screening tool (questionnaire) evaluation
  • Single specialist centre and online recruitment

Main finding

As reported in the abstract

Screening tool final score, median (IQR)
GroupValueSensitivitySpecificity
STL1median 7 (IQR 3.5)93%96%

STL1

Valuemedian 7 (IQR 3.5)
Sensitivity93%
Specificity96%
  • STL1 vs General paediatric: P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeP value
Individual screening tool components (myopia, palate abnormalities, family history of cleft palate, hypermobility)STL1 more likely to have each · secondary analysisHochberg-corrected all P < 0.005

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

A simple questionnaire to prevent blindness: a cross-sectional study screening for Stickler syndrome in children. Rheumatology (Oxford). Published 31 July 2026. doi:10.1093/rheumatology/keag389

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.